Mar. 19, 2026
PAXS CEF: High-Yield Bond Fund, Trading At A Discount To NAV
PIMCO's PAXS closed-end fund offers a 12.28% yield and monthly payouts, but investors should be aware of leverage risks.
Mar. 17, 2026
Granahan Investment Management Invests $1.7M in Beta Bionics
The investment firm acquired a new stake in the medical device company during the third quarter.
Mar. 16, 2026
Fidelity Equity-Income Fund Outperforms in Q4 2025
Fidelity's flagship fund beats benchmark with 3.99% gain.
Mar. 15, 2026
MFS Multimarket Income Trust Declares $0.03 Monthly Dividend
Closed-end fund will pay dividend to shareholders on March 31st
Mar. 13, 2026
Fidelity Dividend Growth Fund Tops S&P 500 in Q4 2025
The fund's Retail Class shares gained 5.09% in the quarter, outperforming the benchmark's 2.66% advance.
Mar. 12, 2026
Fidelity Balanced Fund Outperforms in Q4 2025
FBALX beats hybrid benchmark driven by strong IT security selection
Mar. 10, 2026
Fidelity OTC Portfolio Outperforms Nasdaq in Q4 2025
Fidelity's actively managed fund beats benchmark index with 5.47% gain.
Mar. 10, 2026
Fidelity Growth Company Fund Outperforms in Q4 2025
The fund gained 4.82%, beating its benchmark through strong tech stock selection.
Mar. 8, 2026
Prevail Innovative Wealth Advisors Boosts Vertex Pharmaceuticals Stake
The firm purchased 15,200 additional shares of the biotech company in the third quarter.
Mar. 5, 2026
Fidelity Municipal Income Fund Reports Q4 2025 Results
Diversified national municipal bond strategy sees continued growth in assets under management.
Mar. 4, 2026
Teachers Retirement System of Kentucky Reduces Vertex Pharmaceuticals Stake
The pension fund sold over 25,000 shares of the pharmaceutical company in Q3 2025.
Mar. 4, 2026
Fidelity Total Bond ETF Outperforms in Q4 2025
FBND returned 7.58% in 2025 amid falling interest rates.
Mar. 3, 2026
Wealthedge Investment Advisors Invests $965K in Vertex Pharmaceuticals
The institutional investor purchased 2,465 shares of the pharmaceutical company's stock.
Mar. 2, 2026
Intech Investment Management Boosts State Street Stake
Asset manager increases position in financial services firm by 64.7% in Q3
Feb. 28, 2026
Andra AP fonden Acquires New Shares in Vertex Pharmaceuticals
The institutional investor bought 35,900 shares of the pharmaceutical company's stock, valued at approximately $14,060,000.
